# Al-Bairouni University Hospital

Source: https://onco.cc/institutions/al-bairouni-university-hospital/  
OnCo record `al-bairouni-university-hospital` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Syria's principal public cancer hospital, a Damascus University hospital in Harasta on the edge of Damascus that takes patients from all over the country. In 2025 the IAEA announced a brachytherapy suite for women's cancers at a hospital it calls Al-Biruni Hospital in Damascus, which OnCo takes to be this one.

## Summary

Al-Bairouni University Hospital, in Harasta in Rural Damascus, is described by researchers at Damascus University as the principal cancer centre in Syria, hosting patients from all over the country, most of them of low socioeconomic status; in their review of 2,367 breast cancer charts from January 2019 to May 2022, 58.3% of patients came from outside Damascus and its suburbs. A 2024 systematic review, citing a 2022 book chapter by Manachi and colleagues, reports that its registry recorded about 9,000 new cancers in 2020, that it sees over 60% of Syria's cancer patients and that it is the only treatment centre for thyroid cancer. WHO's 2020 HeRAMS report notes that Rural Damascus has one specialised cancer hospital and that cancer consultations were the highest of any non-communicable disease in public hospitals. The coordinates are an approximate Harasta point.

In June 2025 the IAEA wrote that, through its Rays of Hope initiative and with funding from the government of Italy, it was working with local teams to build Syria's first fully equipped brachytherapy suite at Al-Biruni Hospital in Damascus, which OnCo takes to be this hospital (the article does not give its full name or district), and training radiation oncologists, medical physicists and radiotherapy technologists while the machine was on its way. Studies from the hospital report late diagnosis: 19% of breast cancers were stage IV at diagnosis and fewer than 5% were found by screening mammography. A 2025 survey of 322 of its patients found that 98.8% had never heard of clinical trials.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: Albairouni University Hospital; Al Bairouni University Hospital; Al-Biruni Hospital; Al-Bayrouni Hospital; ABUH
- City: Harasta, Rural Damascus, SY
- Type: cancer-center

## Sources

- Nahhat et al., breast cancer quality of care in Syria (BMC Cancer 2023): https://doi.org/10.1186/s12885-023-11740-2
- IAEA: Director General in Syria to strengthen cooperation in safeguards, cancer care and food security (5 June 2025; read through the Internet Archive): https://web.archive.org/web/20250606055359/https://www.iaea.org/newscenter/news/director-general-in-syria-to-strengthen-cooperation-in-safeguards-cancer-care-and-food-security
- Basha et al., cancer and Syria in conflict: a systematic review (BMC Cancer 2024): https://doi.org/10.1186/s12885-024-13256-9

## Connected records

- technologies: [Brachytherapy](https://onco.cc/technologies/brachytherapy/)
- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Cervical cancer](https://onco.cc/cancers/cervical/), [Thyroid cancer](https://onco.cc/cancers/thyroid/)
- institutions: [International Atomic Energy Agency: Rays of Hope](https://onco.cc/institutions/iaea/), [Ministry of Health, Syrian Arab Republic](https://onco.cc/institutions/syria-ministry-of-health/)
- key papers: [Breast cancer screening, diagnosis and stage at Al-Bairouni University Hospital, 2019 to 2022](https://onco.cc/key-papers/paper-nahhat-breast-cancer-quality-syria-bmc-cancer-2023/), [Cancer and cancer services in Syria during the conflict: a systematic review](https://onco.cc/key-papers/paper-basha-cancer-syria-conflict-review-bmc-cancer-2024/), [Ovarian cancer at three Syrian university hospitals, 2017 to 2021](https://onco.cc/key-papers/paper-apelian-ovarian-cancer-syria-bmc-cancer-2025/), [Willingness to join clinical trials among cancer patients in Syria after the conflict](https://onco.cc/key-papers/paper-kouli-clinical-trial-willingness-syria-jco-go-2026/)

---
JSON: https://onco.cc/api/v1/entities/al-bairouni-university-hospital.json